Mark H. Einstein
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers (NCT00231829) | Mark H. Einstein | 2003-04-01 |
Track Mark H. Einstein automatically
Every clearance here is in the API, with alerts when new ones post.